DEF 14A

Company

Edwards Lifesciences Corp

Filed

March 26, 2026

Period of Report

May 7, 2026

Accession Number

0001099800-26-000015

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →